Saturday, February 3, 2024
This conference has already taken place.
Description
The 2024 Ohio State Community Neurology Symposium will provide information on latest diagnostic guidelines and clinical management approaches for a range of common neurological diseases and conditions, including outpatient stroke, headache, cognitive, neuromuscular, epilepsy surgical program, multiple sclerosis, and general movement disorders. Each talk will be given by a nationally recognized specialist in the field. Cutting edge developments in holistic, multidisciplinary care will be discussed, with a focus on innovative customized, and multidisciplinary symptom management, clinics. A panel of experts will review ongoing and upcoming clinical trials and studies of novel disease modifying agents for individuals with migraines, MS, neuromuscular disorders, seizures, Parkinson’s Disease, and Alzheimer’s disease and other forms of dementia.
To register for the conference, Click Here
Dates and Times
Start: 2/3/2024 8:00 AM
End: 2/3/2024 6:00 PM
Objectives
At the conclusion of this activity, learners will be able to:
1. Recognize with the AHA/ASA clinical guidelines document and how to navigate it for quick reference and introduce a clinical decision-making algorithm for secondary stroke prevention medication and procedures
2. Review new pharmacologic and neuromodulation treatments for migraine rescue and preventative treatment and alternative and complementary treatments in migraine.
3. Employ newly approved Alzheimer's medication including the risks and benefits for the Lecanemab.
4. Explore the latest advancements in diagnosing and treating neuropathies and motor neuron disorders, which include Guillain-Barré Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), paranodopathies, Small Fiber Neuropathy, and Spinal Muscular Atrophy (SMA).
5. Recognizing the patients with drug-resistant epilepsy
6. Recognize the common clinical presentation and diagnostic criteria for multiple sclerosis and related disorders.
7. Identify the most up to date strategies in management of Parkinson’s disease.
8. Identify OSU’s Parkinson’s Disease clinical trials.
9. Recognize the latest emerging clinical trials for cognitive disorders and dementia.
Agenda
.png)
Pricing
| Tier | Price |
|---|---|
| This is a free event | $0.00 |
Speakers
Panels
Location
OSU Fawcett Center and virtual (Instuctions on on-line participation sent closer to the event)
2400 Olentangy River Road
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.